ECMO Clinical Trials

16 recruitingLast updated: May 11, 2026

There are 16 actively recruiting ecmo clinical trials across 14 countries. Studies span Not Applicable, Phase 1, Phase 2. Top locations include Beijing, Beijing Municipality, China, Vienna, Austria, Amsterdam, North Holland, Netherlands. Updated daily from ClinicalTrials.gov.


ECMO Trials at a Glance

16 actively recruiting trials for ecmo are listed on ClinicalTrialsFinder across 6 cities in 14 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in Beijing, Vienna, and Amsterdam. Lead sponsors running ecmo studies include Medical University of Vienna, Beijing Anzhen Hospital, and Atlantic Health System.

Browse ecmo trials by phase

Treatments under study

About ECMO Clinical Trials

Looking for clinical trials for ECMO? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new ECMO trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about ECMO clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 116 of 16 trials

Recruiting

Improving Sedation Practice in Critically Ill Adult Patients Using a Co-designed Sedation Protocol

Intensive Care MedicineOpioid analgesiaExtracorporeal Membrane Oxygenation (ECMO)+5 more
Guy's and St Thomas' NHS Foundation Trust120 enrolled1 locationNCT07032987
Recruiting
Not Applicable

Standby Cannulated ECMO for High-Risk Percutaneous Coronary Intervention

ECMOHigh-risk PCI
Beijing Anzhen Hospital176 enrolled1 locationNCT06274411
Recruiting
Not Applicable

Comparing a Suture-based System for the Removal of Arterial and Veinous ECMO Cannulas to the Standard Approach

VA-ECMO
IHF GmbH - Institut für Herzinfarktforschung102 enrolled2 locationsNCT07019662
Recruiting
Phase 1Phase 2

Influence of Personalized Lung Volume Optimization Maneuver on Lung Function and Cardiac Performance in Children

Mechanical VentilationCongenital Heart DiseaseChildren+8 more
Charite University, Berlin, Germany80 enrolled1 locationNCT07193719
Recruiting
Not Applicable

Early Intra-aortic Balloon Pump Use After Venoarterial Extracorporeal Membrane Oxygenation

ECMO
Beijing Anzhen Hospital358 enrolled1 locationNCT06872021
Recruiting

Plasma Biomarkers and Platelet Morphology of Extracorporeal CardioPulmonary Resuscitation

Extracorporeal Membrane Oxygenation (ECMO)Cardiac Arrest
Central China Fuwai Hospital of Zhengzhou University130 enrolled1 locationNCT07113769
Recruiting

Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR

Severe aortic stenosisCardiogenic ShockTrans-catheter Aortic Valve Implantation+1 more
Atlantic Health System30 enrolled2 locationsNCT07309029
Recruiting
Not Applicable

Hemodynamic Monitoring and Fluid Responsiveness in Venovenous Extracorporeal Membrane Oxygenation (VV ECMO) - "HemodynamECMOnitoring-VV Study"

PneumoniaARDSHemodynamic Monitoring+3 more
Medical University of Vienna30 enrolled1 locationNCT06593717
Recruiting
Not Applicable

Hemodynamic Monitoring and Fluid Responsiveness in Venoarterial Extracorporeal Membrane Oxygenation (VA ECMO) - "HemodynamECMOnitoring-VA Study"

PneumoniaARDSHemodynamic Monitoring+3 more
Medical University of Vienna30 enrolled1 locationNCT06593756
Recruiting
Not Applicable

Hypothermia Versus Normothermia After Extracorporeal Cardiopulmonary Resuscitation for Out-of-hospital Cardiac Arrest

Out of Hospital Cardiac Arrest (OHCA)TemperatureECMO Treatment+1 more
Kagawa University468 enrolled28 locationsNCT06776549
Recruiting

Prognosis of Veno-Venous Extracorporeal Membrane Oxygenation in Emergency Thoracic Surgery

Emergency surgeryMortalityThoracic Surgery+5 more
Centre Hospitalier Universitaire, Amiens380 enrolled1 locationNCT07016685
Recruiting

Prospective Observational Pilot Study of LMWH Versus UFH as ECMO Anticoagulation in Lung Transplantation

Extracorporeal Membrane Oxygenation (ECMO)Anticoagulants and Bleeding DisordersLung transplantation
University Hospital, Motol40 enrolled1 locationNCT06868823
Recruiting
Not Applicable

Restrictive Versus Liberal Thresholds for RBC Transfusion in ECMO

TransfusionAnemiaECMO+2 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)526 enrolled12 locationsNCT06560164
Recruiting
Not Applicable

A Novel Strategy of ECMO Management Using Nafamostat for Regional Combined With Low Intensity Systematic Anticoagulation

ECMO
Beijing Chao Yang Hospital60 enrolled1 locationNCT06676085
Recruiting

The ECMOCYP (cytochromes P450 Activity) Study

Cardiogenic ShockECMOTemporary Mechanical Circulatory Support
University Hospital, Geneva46 enrolled1 locationNCT06662084
Recruiting

Analgesic, Sedative and Antibiotic Pharmacokinetics during Extracorporeal Membrane Oxygenation: Understanding altered pharmacokinetics to improve patient outcomes.

Alterations to the pharmacokinetics of broad spectrum antibiotics (ceftriaxone, cefepime, meropenem, gentamicin, ciprofloxacin, ticarcillin-clavulanate, piperacillin-tazobactum, vancomycin, linezolid, caspofungin, fluconazole, voriconazole, oseltamivir/oseltamivir carboxylate) in critically ill patients receiving ECMO.Alterations to the pharmacokinetics of sedative and analgesic drugs and their metabolites (morphine - morphine 3 glucorunide, morphine 6 glucuronide, midazolam - 1 and 4 hydroxy midazolam, fentanyl - norfentanyl, dexmedetiomedine, propofol, thiopentone) in critically ill patients receiving ECMO.
Critical Care Research Group160 enrolled4 locationsACTRN12612000559819